Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01383941 · ClinicalTrials.gov registry record
Asthma Phenotypes in the Inner City
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 717
- Enrollment target
NCT01383941 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 717 participants.
The verdict
NCT01383941 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 717 participants
- Enrollment target
Study Summary
This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17 years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.
Interventions
- DRUG Guidelines-based asthma and rhinitis/rhinosinusitis therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 717 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01383941
The ClinicalTrials.gov registry entry for NCT01383941 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 717 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Guidelines-based asthma and rhinitis/rhinosinusitis therapy is the first listed.
NCT01383941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01383941 about?
NCT01383941 is a clinical study titled "Asthma Phenotypes in the Inner City". This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17 years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.
What is the current status of trial NCT01383941?
This trial is currently completed. The enrollment target is 717 participants. The study started on 2011-08. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01383941?
The interventions under investigation include: Guidelines-based asthma and rhinitis/rhinosinusitis therapy (DRUG).
Who is sponsoring clinical trial NCT01383941?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.